Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Autoría

autor: Isabelle Ray-Coquard, David Cibula, Ignace Vergote, Sandro Pignata, Bradley J. Monk, Jalid Sehouli, John Farley, Regina Berger, Esther Drill, Anneke Westermann, Ignacio Romero, Felix Hilpert, Peter Vuylsteke, Josep M. del Campo, David M. O'Malley, Cristina Churruca, Gopa Iyer, Kathleen N. Moore, Nicoletta Colombo, Robert L Coleman, Susana Banerjee, Amit M. Oza, Rachel N. Grisham, Gunnar B. Kristensen, Martin K Oehler, Carol Aghajanian, Andrew R Clamp, Christian Marth, Elsa Kalbacher, Mansoor Raza Mirza